These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 26842650)

  • 1. Vaccinating against HPV: A Call to Action.
    Poh A
    Cancer Discov; 2016 Mar; 6(3):222-3. PubMed ID: 26842650
    [No Abstract]   [Full Text] [Related]  

  • 2. Human papillomavirus (HPV) vaccines: limited cross-protection against additional HPV types.
    Herrero R
    J Infect Dis; 2009 Apr; 199(7):919-22. PubMed ID: 19236278
    [No Abstract]   [Full Text] [Related]  

  • 3. Human papillomavirus vaccine: widening the scope for cancer prevention.
    No JH; Kim MK; Jeon YT; Kim YB; Song YS
    Mol Carcinog; 2011 Apr; 50(4):244-53. PubMed ID: 21465574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reducing the burden of cervical cancer and HPV-related diseases through vaccination. Introduction.
    Cox JT
    Curr Opin Obstet Gynecol; 2006 Feb; 18 Suppl 1():s3-4. PubMed ID: 16520682
    [No Abstract]   [Full Text] [Related]  

  • 5. Prophylactic HPV vaccination for the prevention of cervical cancer.
    Hernandez BY
    Hawaii Med J; 2007 Jul; 66(7):190-1. PubMed ID: 17879858
    [No Abstract]   [Full Text] [Related]  

  • 6. Cost-utility analysis of vaccination against HPV in Israel.
    Ginsberg GM; Fisher M; Ben-Shahar I; Bornstein J
    Vaccine; 2007 Sep; 25(37-38):6677-91. PubMed ID: 17706844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No Vacillation on HPV Vaccination.
    Sipp D; Frazer IH; Rasko JEJ
    Cell; 2018 Mar; 172(6):1163-1167. PubMed ID: 29522737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPV vaccines and cervical cancer.
    Bosch FX
    Ann Oncol; 2008 Jul; 19 Suppl 5():v48-51. PubMed ID: 18611900
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevention strategies against the human papillomavirus: the effectiveness of vaccination.
    Stanley M
    Gynecol Oncol; 2007 Nov; 107(2 Suppl 1):S19-23. PubMed ID: 17938013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One in four California adolescent girls have had human papillomavirus vaccination.
    Grant D; Kravitz-Wirtz N; Breen N; Tiro JA; Tsui J
    Policy Brief UCLA Cent Health Policy Res; 2009 Feb; (PB2009-3):1-6. PubMed ID: 19288623
    [No Abstract]   [Full Text] [Related]  

  • 11. Elimination of cervical cancer depends on HPV vaccination and primary HPV screening.
    Harper DM; Jimbo M
    Lancet Infect Dis; 2021 Oct; 21(10):1342-1344. PubMed ID: 34081924
    [No Abstract]   [Full Text] [Related]  

  • 12. An Update on Human Papilloma Virus Vaccines: History, Types, Protection, and Efficacy.
    Yousefi Z; Aria H; Ghaedrahmati F; Bakhtiari T; Azizi M; Bastan R; Hosseini R; Eskandari N
    Front Immunol; 2021; 12():805695. PubMed ID: 35154080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cervical cancer: the second-generation vaccines move forward.
    Tuma RS
    J Natl Cancer Inst; 2009 Jun; 101(11):774-5. PubMed ID: 19470948
    [No Abstract]   [Full Text] [Related]  

  • 14. Human papillomavirus vaccines.
    Satyaprakash A; Creed R; Ravanfar P; Mendoza N
    Dermatol Ther; 2009; 22(2):150-7. PubMed ID: 19335726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The new era of cervical cancer prevention: HPV vaccination.
    Monk BJ; Herzog TJ
    Gynecol Oncol; 2008 May; 109(2 Suppl):S1-3. PubMed ID: 18482553
    [No Abstract]   [Full Text] [Related]  

  • 16. Broad-spectrum human papillomavirus vaccines: new horizons but one step at a time.
    Bosch FX
    J Natl Cancer Inst; 2009 Jun; 101(11):771-3. PubMed ID: 19470950
    [No Abstract]   [Full Text] [Related]  

  • 17. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Markowitz LE; Dunne EF; Saraiya M; Lawson HW; Chesson H; Unger ER; ;
    MMWR Recomm Rep; 2007 Mar; 56(RR-2):1-24. PubMed ID: 17380109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benefits of vaccinating young adult women with a prophylactic quadrivalent human papillomavirus (types 6, 11, 16 and 18) vaccine.
    Monsonego J; Cortes J; Greppe C; Hampl M; Joura E; Singer A
    Vaccine; 2010 Nov; 28(51):8065-72. PubMed ID: 20971114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress in Vaccination of Prophylactic Human Papillomavirus Vaccine.
    Zhou X; Sun L; Yao X; Li G; Wang Y; Lin Y
    Front Immunol; 2020; 11():1434. PubMed ID: 32754157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low affordability may limit the effect of cervical cancer vaccination in central and eastern European countries.
    Zubor P; Danko J; Kajo K; Szunyogh N
    J Clin Oncol; 2007 Dec; 25(34):5534-7. PubMed ID: 18048836
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.